...
首页> 外文期刊>Clinical Rheumatology >Shrinking lung syndrome masked by pleuropericarditis: a case report and review of the literature
【24h】

Shrinking lung syndrome masked by pleuropericarditis: a case report and review of the literature

机译:胸膜腹膜炎掩盖的萎缩性肺综合征:一例报道并文献复习

获取原文
获取原文并翻译 | 示例

摘要

The purpose of this article is to present an unusual case of shrinking lung syndrome (SLS) masked by pleuropericarditis with a review of the literature. We report a case of SLS in a 44-year-old woman in which the diagnosis was initially confounded by concurrent pleuropericarditis. The English medical literature was comprehensively reviewed for SLS for its presentation, clinical findings, diagnosis, treatment, with specific focus on its pathogenesis. SLS is a rare respiratory complication associated with systemic lupus erythematosus (SLE). The main manifestation of the disease is unexplained dyspnea, chest pain, and orthopnea. Lung volume reduction without parenchymal abnormalities along with restrictive ventilatory defect on pulmonary function test (PFT) is the hallmarks of this condition. Pathogenesis, treatment, and prognosis of SLS are not well described due to the small number of reported cases. The diagnosis of SLS in our patient was made based on imaging, PFT, and the exclusion of other respiratory diseases associated with SLE. Treatment with corticosteroid and intravenous cyclophosphamide was initiated due to simultaneously diagnosed renal involvement. Our case demonstrates the salient features of SLS. It emphasizes that although SLS is a rare disease limited to small subset of patients with SLE, it should be considered in patients with SLE with unexplained dyspnea. Moreover, symptoms of pleuropericarditis can mask and delay the diagnosis of SLS. Prompt diagnosis and treatment can lead to a decrease in morbidity and stabilization of pulmonary function test abnormalities.
机译:本文的目的是介绍一种由胸膜腹膜炎掩盖的肺萎缩综合征(SLS)的罕见病例,并进行文献综述。我们报告了一名44岁女性的SLS病例,其中该诊断最初是由并发胸膜腹膜炎引起的。对SLS的英文医学文献进行了全面的综述,以介绍SLS的表现,临床发现,诊断,治疗,并特别关注其发病机理。 SLS是与系统性红斑狼疮(SLE)相关的罕见呼吸道并发症。该病的主要表现是原因不明的呼吸困难,胸痛和正气呼吸。肺功能检查中无肺实质减少以及肺通气受限的通气受限是这种情况的标志。由于报道的病例很少,因此并未很好地描述SLS的发病机制,治疗和预后。根据影像学,PFT和排除与SLE相关的其他呼吸系统疾病,对我们患者进行SLS诊断。由于同时诊断出肾脏受累,开始使用糖皮质激素和静脉内环磷酰胺治疗。我们的案例展示了SLS的显着特征。它强调,尽管SLS是一种罕见的疾病,仅限于一小部分SLE患者,但对于原因不明的呼吸困难的SLE患者应考虑使用SLS。而且,胸膜腹膜炎的症状可以掩盖并延迟SLS的诊断。及时的诊断和治疗可降低发病率,并稳定肺功能检查异常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号